|
|
|
|
|
|
|
About Primm
The Company
Primm was founded in 1990, initially as a provider of synthetic oligonucleotides, and has since expanded its services to the areas of peptide synthesis, polyclonal and monoclonal antibodies, kits for DNA purification, DNA and protein sequencing, mass spectrometry, development of recombinant proteins and immunometric assays, animal services and pre-clinical studies.
In the last few years, Primm has also invested in proprietary R&D projects based on its know-how, becoming a fully technology-based company.
Locations
At present, Primm has laboratories, manufacturing facilities, and commercial offices in Italy, Switzerland and USA.
Since 1995, its main Italian facility is located at the San Raffaele Biomedical Science Park, Milan, providing several core services to the local scientific community and where scientific interactions are being developed on a routine basis.
In 1998, the company expanded its activities through the acquisition of both laboratories and a top-class animal facility located in the area of Treviso (Italy).
This site is used for the production of polyclonal and monoclonal antibodies and to develop and perform various services, such as animal breeding and maintenance and pre-clinical studies. |
|
|
